Comparative efficacy: what we know, what we need to know, and how we can get there.
作者信息
Malozowski Saul
出版信息
Ann Intern Med. 2008 May 6;148(9):702-3. doi: 10.7326/0003-4819-148-9-200805060-00010.
Abstract
摘要
相似文献
1
Comparative efficacy: what we know, what we need to know, and how we can get there.比较疗效：我们已知的、我们需要知道的以及我们如何能够实现（目标）。
Ann Intern Med. 2008 May 6;148(9):702-3. doi: 10.7326/0003-4819-148-9-200805060-00010.
2
Osteoporosis drug licensed for women with high fracture risk.
Am J Health Syst Pharm. 2010 Jul 1;67(13):1046. doi: 10.2146/news100046.
3
Review of comparative effectiveness of treatments to prevent fractures.
Ann Intern Med. 2008 Jun 3;148(11):885-6; author reply 887. doi: 10.7326/0003-4819-148-11-200806030-00019.
4
Comparative effectiveness of pharmacologic treatments to prevent fractures: is this all we need to know?预防骨折的药物治疗的比较效果：这就是我们需要了解的全部内容吗？
Ann Intern Med. 2014 Nov 18;161(10):755-6. doi: 10.7326/M14-1942.
5
Drug treatment for low bone density or osteoporosis to prevent fractures: a clinical practice guideline from the American College of Physicians.用于预防骨折的低骨密度或骨质疏松症的药物治疗：美国医师学会临床实践指南
Ann Intern Med. 2008 Sep 16;149(6):I46. doi: 10.7326/0003-4819-149-6-200809160-00002.
6
Is too much intervention recommended in the ACP osteoporosis treatment guidelines?美国内科医师学会骨质疏松症治疗指南中推荐的干预措施过多了吗？
Ann Intern Med. 2009 Feb 17;150(4):285-6; author reply 286-7. doi: 10.7326/0003-4819-150-4-200902170-00024.
7
Indications and Outcomes of Osteoporosis and Bone Modulation Therapies.骨质疏松症及骨调节疗法的适应症与治疗结果
Oral Maxillofac Surg Clin North Am. 2015 Nov;27(4):567-71. doi: 10.1016/j.coms.2015.06.009. Epub 2015 Sep 9.
8
Third-generation SERMs may face uphill battle.第三代选择性雌激素受体调节剂可能面临艰难挑战。
J Natl Cancer Inst. 2010 Nov 17;102(22):1690-2. doi: 10.1093/jnci/djq477. Epub 2010 Nov 8.
9
[New bone density conservation agents for osteoporosis under research and development: ED-71].[正在研发的用于骨质疏松症的新型骨密度保护剂：依替膦酸二钠（ED-71）]
Nihon Rinsho. 2007 Nov 28;65 Suppl 9:454-8.
10
The silent thief: diagnosis and management of osteoporosis.无声的窃贼：骨质疏松症的诊断与管理
Orthop Nurs. 2011 May-Jun;30(3):162-71; quiz 172-3. doi: 10.1097/NOR.0b013e318219ab9d.
引用本文的文献
1
The effects of industry sponsorship on comparator selection in trial registrations for neuropsychiatric conditions in children.行业赞助对儿童神经精神疾病试验注册中对照选择的影响。
PLoS One. 2013 Dec 23;8(12):e84951. doi: 10.1371/journal.pone.0084951. eCollection 2013.
Zotero 插件